announces

Femasys Announces Historic Milestone with European Approval of FemBloc, the First Non-Surgical Permanent Birth Control

ATLANTA, June 25, 2025 (GLOBE NEWSWIRE) -- Femasys Inc., (Nasdaq: FEMY), a leading biomedical innovator addressing significant unmet needs in…

5 months ago

LightWave Acquisition Corp. Announces Pricing of $187,500,000 Initial Public Offering

June 24, 2025 18:44 ET  | Source: LightWave Acquisition Corp. Dallas, TX, June 24, 2025 (GLOBE NEWSWIRE) -- LightWave Acquisition…

5 months ago

BlackRock Canada Announces Final June Cash Distributions for the iShares Premium Money Market ETF

TORONTO, June 24, 2025 (GLOBE NEWSWIRE) -- BlackRock Asset Management Canada Limited (“BlackRock Canada”), an indirect, wholly-owned subsidiary of BlackRock,…

5 months ago

CROSSJECT announces a successful capital increase of 5.7 million following full exercise of the extension clause

Press release CROSSJECT announces a successful capital increase of €5.7 million following full exercise of the extension clause Transaction raised…

5 months ago

WF Holding Ltd announces entry into the digital cryptocurrency field

KUALA LUMPUR, Malaysia, June 24, 2025 /PRNewswire/ -- Today, WF Holding Ltd (stock code: WFF) officially announced its entry into the…

5 months ago

WF Holding Ltd announces plans for major investment in China

KUALA LUMPUR, Malaysia, June 24, 2025 /PRNewswire/ -- WF Holding Ltd (Stock Code: WFF), a manufacturer of fiberglass reinforced plastic,…

5 months ago

Acceleware Announces Strategic Collaboration and Distribution Agreement with Scovan

CALGARY, Alberta, June 23, 2025 (GLOBE NEWSWIRE) -- Acceleware® Ltd. (“Acceleware” or the “Company”) (TSX-V: AXE), a leading innovator of…

6 months ago

RICH Miner Announces Global Expansion and Zero-Hassle Cloud Mining for Robinhood Users

London, UK, June 22, 2025 (GLOBE NEWSWIRE) -- RICH Miner, an intelligent cloud mining platform, has officially announced its global…

6 months ago

Abvance Therapeutics Announces Presentation of Human Clinical Data at the 85th Scientific Sessions of the American Diabetes Association

CHICAGO, June 21, 2025 (GLOBE NEWSWIRE) -- Abvance Therapeutics, a biotechnology company developing next generation glucagon analogs and therapies to…

6 months ago